GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InVivo Therapeutics Holdings Corp (OTCPK:NVIVQ) » Definitions » Cyclically Adjusted Book per Share

InVivo Therapeutics Holdings (InVivo Therapeutics Holdings) Cyclically Adjusted Book per Share : $7,048.41 (As of Sep. 2023)


View and export this data going back to 2010. Start your Free Trial

What is InVivo Therapeutics Holdings Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

InVivo Therapeutics Holdings's adjusted book value per share for the three months ended in Sep. 2023 was $2.872. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $7,048.41 for the trailing ten years ended in Sep. 2023.

During the past 12 months, InVivo Therapeutics Holdings's average Cyclically Adjusted Book Growth Rate was -4.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 18.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 13.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of InVivo Therapeutics Holdings was 62.10% per year. The lowest was 4.50% per year. And the median was 15.50% per year.

As of today (2024-05-15), InVivo Therapeutics Holdings's current stock price is $0.389. InVivo Therapeutics Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 was $7,048.41. InVivo Therapeutics Holdings's Cyclically Adjusted PB Ratio of today is 0.00.


InVivo Therapeutics Holdings Cyclically Adjusted Book per Share Historical Data

The historical data trend for InVivo Therapeutics Holdings's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InVivo Therapeutics Holdings Cyclically Adjusted Book per Share Chart

InVivo Therapeutics Holdings Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,329.51 4,508.66 4,669.51 6,674.78 7,490.76

InVivo Therapeutics Holdings Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,406.05 7,490.76 8,146.09 7,532.84 7,048.41

Competitive Comparison of InVivo Therapeutics Holdings's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, InVivo Therapeutics Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InVivo Therapeutics Holdings's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InVivo Therapeutics Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where InVivo Therapeutics Holdings's Cyclically Adjusted PB Ratio falls into.



InVivo Therapeutics Holdings Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, InVivo Therapeutics Holdings's adjusted Book Value per Share data for the three months ended in Sep. 2023 was:

Adj_Book= Book Value per Share /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=2.872/129.8595*129.8595
=2.872

Current CPI (Sep. 2023) = 129.8595.

InVivo Therapeutics Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201312 12,276.190 98.326 16,213.225
201403 8,630.476 99.695 11,241.837
201406 11,302.419 100.560 14,595.602
201409 10,840.000 100.428 14,016.806
201412 4,734.400 99.070 6,205.801
201503 7,381.295 99.621 9,621.770
201506 10,709.091 100.684 13,812.310
201509 11,851.389 100.392 15,330.137
201512 11,516.327 99.792 14,986.156
201603 24,410.588 100.470 31,551.051
201606 22,124.118 101.688 28,253.325
201609 19,204.678 101.861 24,483.462
201612 16,929.240 101.863 21,582.215
201703 14,016.959 102.862 17,695.862
201706 11,028.488 103.349 13,857.440
201709 7,830.220 104.136 9,764.465
201712 5,524.590 104.011 6,897.538
201803 4,001.442 105.290 4,935.205
201806 -350.919 106.317 -428.626
201809 1,629.806 106.507 1,987.159
201812 1,298.227 105.998 1,590.476
201903 1,091.378 107.251 1,321.447
201906 842.834 108.070 1,012.774
201909 619.149 108.329 742.203
201912 253.427 108.420 303.541
202003 92.942 108.902 110.829
202006 51.357 108.767 61.316
202009 39.974 109.815 47.270
202012 20.297 109.897 23.984
202103 18.623 111.754 21.640
202106 17.007 114.631 19.266
202109 15.281 115.734 17.146
202112 13.217 117.630 14.591
202203 11.321 121.301 12.120
202206 9.211 125.017 9.568
202209 7.257 125.227 7.525
202212 6.481 125.222 6.721
202303 4.339 127.348 4.425
202306 3.728 128.729 3.761
202309 2.872 129.860 2.872

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


InVivo Therapeutics Holdings  (OTCPK:NVIVQ) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

InVivo Therapeutics Holdings's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.389/7048.41
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


InVivo Therapeutics Holdings Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of InVivo Therapeutics Holdings's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


InVivo Therapeutics Holdings (InVivo Therapeutics Holdings) Business Description

Traded in Other Exchanges
Address
One Kendall Square, Suite B14402, Building 1400 West, 4th Floor, Cambridge, MA, USA, 02139
InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.
Executives
Brice Foose 10 percent owner 236 SILENT MEADOW DRIVE, LAKE ST. LOUIS MO 63367
Daniel R Marshak director C/O CAMBREX CORP, ONE MEADOWLANDS PLZ, EAST RUTHERFORD NJ 07073
Christina Morrison director ARAMARK, 1101 MARKET STREET, PHILADELPHIA PA 19107
Richard M. Toselli director, officer: CEO and CMO C/O INVIVO THERAPEUTICS HOLDINGS CORP., 1 KENDALL SQUARE, SUITE B14402, CAMBRIDGE MA 02139
Richard Christopher officer: Chief Financial Officer C/O LUCID, INC., 50 METHODIST HILL DR, SUITE 1000, ROCHESTER NY 14623
C Ann Merrifield director
Bob Rosenthal director 20 NEWBURY ST, BOSTON MA 02116
Heather Hamel officer: Chief Legal Officer and GC ONE KENDALL SQUARE, BUILDING 1400 WEST, FLOOR 4, CAMBRIDGE MA 02139
Jeffrey Modestino officer: See Remarks C/O INVIVO THERAPEUTICS HOLDINGS CORP., 1 KENDALL SQUARE, SUITE B14403, CAMBRIDGE MA 02139
Christopher Mcnulty officer: Chief Financial Officer C/O INVIVO THERAPEUTICS HOLDINGS CORP., 1 KENDALL SQUARE, SUITE B14402, CAMBRIDGE MA 02139
Melanie Golarz officer: Interim CFO C/O INVIVO THERAPEUTICS HOLDINGS CORP., 1 KENDALL SQUARE, SUITE B14402, CAMBRIDGE MA 02139
Jeffrey S. Hatfield director 11080 ROSELLE STREET, SAN DIEGO CA 92121
Pamela J Stahl officer: Chief Commercial Officer ONE KENDALL SQUARE, SUITE B14402, CAMBRIDGE MA 02139
Richard John Roberts director ONE BROADWAY, 14TH FLOOR, CAMBRIDGE MA 02142
Masuoka K. Lorianne officer: Chief Medical Officer C/O NEKTAR THERAPEUTICS, 201 INDUSTRIAL ROAD, SAN CARLOS CA 94070